CA
CLBT icon

CoreCap Advisors’s Cellebrite CLBT Stock Holding History

CoreCap Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.5K Hold
2,980
– – ﹤0.01% 1466
2026
Q1 		$41.1K Hold
2,980
– – ﹤0.01% 1390
2025
Q4 		$53.7K Hold
2,980
– – ﹤0.01% 1302
2025
Q3 		$55.2K Hold
2,980
– – ﹤0.01% 1276
2025
Q2 		$47.7K Buy
2,980
+880
+42% +$15.7K ﹤0.01% 1280
2025
Q1 		$40.8K Hold
2,100
– – ﹤0.01% 1257
2024
Q4 		$46.3K Hold
2,100
– – ﹤0.01% 1212
2024
Q3 		$35.4K Hold
2,100
– – ﹤0.01% 1334
2024
Q2 		$25.1K Buy
+2,100
New +$23.5K ﹤0.01% 835

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

CoreCap Advisors's CLBT Position: Q2 2026 in Review

CoreCap Advisors held its Cellebrite (CLBT) position steady in Q2 2026 at 2,980 shares worth $43.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1466.

CoreCap Advisors first reported a position in CLBT in Q2 2024 and has held it in 9 quarters since. The position peaked at $55.2K in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • CoreCap Advisors held 2,980 shares of Cellebrite worth $43.5K as of Q2 2026.
  • CoreCap Advisors left its Cellebrite share count unchanged in Q2 2026.
  • Cellebrite made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1466 holding.
  • CoreCap Advisors first reported a position in Cellebrite in Q2 2024 and has held it in 9 quarters since.
  • CoreCap Advisors's Cellebrite position peaked at $55.2K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.